Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>Products>This Product

MaxDiscovery™ Mouse IL-2 ELISA Test Kit

Product Description
The MaxDiscovery™ Mouse IL-2 ELISA Test Kit is designed for quantitative determination of the concentration of mouse IL-2 serum, plasma, and cell culture supernatant. Mouse interleukin 2 (IL-2) is a T cell-derived cytokine known to promote growth and differentiation of T cells and to have pleiotropic effects on many other leukocytes. IL-2 is rapidly secreted upon activation by naive T helper cells and certain subsets of memory cells. Mature mouse IL-2 is a 15.5 kDa protein containing 133 amino acid residues after several posttranslational processing. It is primarily produced by activated T and B cells and macrophages in mice. It is also produced by other cell types such as fibroblasts and CD24+ cells when stimulated by TNF-a, IL-1, IL-2 and IFN-?. Mouse IL-2 stimulates growth of macrophages, granulocytes, dendritic cells and other granulose cells. There are two kinds of IL-2, a membrane-bound form and a soluble form in a complex associated with the extracellular matrix. Both play biological functions based on research. In addition, recombinant IL-2 generated in E. coli is nonglycosylated but is biologically active.
Product MaxDiscovery™ Mouse IL-2 ELISA Test Kit
Company BIOO Scientific - Product Directory
Price Request a quote
More Information View company product page
Catalog Number 2005-01
Quantity 1 x 96 wells
Company Logo

BIOO Scientific - Product Directory
3913 Todd Lane Suite 312 Austin, TX 78744, USA

Tel: +1 512-707-8993
Fax: +1 512-707-8122

Scientific News
Enzyme Malfunction May be Why Binge Drinking Can Lead to Alcoholism
A new study in mice shows that restoring the synthesis of a key brain chemical tied to inhibiting addictive behavior may help prevent alcohol cravings following binge drinking.
Cell's Waste Disposal System Regulates Body Clock Proteins
New way to identify interacting proteins could identify potential drug targets.
Compound Doubles Up On Cancer Detection
Researchers have found that tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer.
Promising Drug Candidate to Treat Chronic Itch
In a new study, scientists from the Florida campus of The Scripps Research Institute (TSRI) describe a class of compounds with the potential to stop chronic itch without the adverse side effects normally associated with medicating the condition.
Are Changes to Current Colorectal Cancer Screening Guidelines Required?
Editorial suggests more research is needed to pinpoint age to end aggressive screening.
Assessing Cancer Patient Survival and Drug Sensitivity
RNA editing events another way to investigate biomarkers and therapy targets.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Potential Target for Treatment of Autism
Grant of $2.4 million will support further research.
Sniffing Out Cancer
Scientists have been exploring new ways to “smell” signs of cancer by analyzing what’s in patients’ breath.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.


Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos